Abstract

Favorable Prognosis in Patients Undergoing Hemodialysis Who Received a 23-Valent Pneumococcal Polysaccharide Vaccine Compared With Those Who Received a 13-Valent Pneumococcal Protein-Conjugate

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call